by Brooks | Jun 11, 2025 | Breast Cancer, Cancer, Precision Health Personalized Medicine, Women's Health, Wondered?
Zoe Huestis & Miley Nguyen, PharmD, RPh Have YOU EVER WONDERED …how antidepressants could impact breast cancer treatment? Many women on tamoxifen for breast cancer treatment are co-prescribed antidepressants such as selective serotonin reuptake inhibitors...
by Brooks | Jun 8, 2025 | Precision Health Personalized Medicine
UGenome’s build success from its Operations, Policies, SOPs, and best practices with its “5-point UGenome’s 5-point Quality Management System is driven by 5 Principles: 1. Human Resources Training, 2. Data Handling and Protection, 3. Customer Service...
by Brooks | Jun 4, 2025 | Pharmacogenomics, Precision Health Personalized Medicine, Reduce Adverse Drug Reactions, Women's Health, Wondered?
Navya Brinda & Zoe Huestis Have YOU EVER WONDERED …why NSAID use in women calls for extra care? NSAIDs are the most widely used pain and anti-inflammatory medications, with higher usage reported in women than men (Farkouh et al., 2021) Women are twice as...
by Brooks | Jun 3, 2025 | Digital Twin-in silico, News, Precision Health Personalized Medicine, Reduce Adverse Drug Reactions, Research PGx
On May 7, 2025 UGenome AI’s Founder & CEO Zachary S. Brooks, PhD, EMBA gave a talk at University of Liverpool on “PGx & Digital Twins” supported by Wahbi El-Bouri, Senior Lecturer, Digital Twins and In Silico Clinical Trials. Thank you...
by Brooks | Jun 2, 2025 | News, Precision Health Personalized Medicine, Research PGx
On April 28, 2025, UGenome AI team mates Ayse ULGEN, PhD, MGM, Peter Bannister, and Zachary S. Brooks, PhD, EMBA gave a talk to Nottingham Trent University entitled: “UGenome AI’s promise to revolutionize the pharmacogenomics research –...
by Brooks | May 30, 2025 | News, Nutrigenomics, Pediatrics-children, Pharmacogenomics, Precision Health Personalized Medicine, Rare disease
May 30, 2025 TUCSON, AZ – UGenome AI, a pioneer in genomic technology, today announced an expanded partnership with Jura Health, Inc. to integrate both pharmacogenomic and nutrigenomic insights into the diagnosis of rare diseases and the development of personalized...
